Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Possible link between androgens and COVID-19 severity; more research needed.

BAF200 is essential for proper heart and coronary artery formation.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Some drugs may help treat both COVID-19 and radiation injury.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

People with chronic Hepatitis C often have skin problems like itching and contact dermatitis, especially older individuals and women.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.